Rethinking Cytotoxicity: Do Cytotoxicity Results Predict In Vivo Outcomes?

Join us for an insightful webinar where we delve into the predictive value of cytotoxicity assays in determining in vivo outcomes for medical devices. Cytotoxicity assays have long been a cornerstone in the biocompatibility testing of medical devices due to their in vitro nature, cost-effectiveness, and quick turnaround. However, the true predictive power of these assays in relation to in vivo outcomes of acute systemic toxicity, intracutaneous irritation, and sensitization remains unclear. In this webinar, we will explore extensive data analyses conducted on biocompatibility studies to uncover whether cytotoxicity results can reliably predict these critical biological endpoints.

Key Takeaways:

• Understanding Cytotoxicity Assays: Explore the traditional role of cytotoxicity assays in biocompatibility testing and their perceived predictive value.
• Data-Driven Insights: Learn about the extensive data analysis conducted on thousands of biocompatibility studies and the findings regarding correlations between cytotoxicity results and in vivo outcomes.
• Future Directions: Discuss the implications of these findings for regulatory practices and future research directions in biocompatibility testing.

Don't miss this opportunity to gain valuable insights and engage with experts in the field.